1. Home
  2. Research and Development
  3. Partnering in Research

Research and Development

Partnering in Research

Our Approach to Partnering with Academia

RaQualia Pharma actively seeks partnerships with universities and public research institutions around the world that have a high degree of expertise and superior technology. Based on our concept of open collaboration, we believe we can create new value by maximizing our mutual strengths through joint research and development.

The following are core areas for research collaboration.

  1. Development of analytical evaluation systems
  2. Search for lead compounds
  3. Implementation of biological testing
  4. Development of research tools

For details, please contact our Partnering Officer.

Page Top

Corporate Information
CEO Message
Company Overview
Vision, Management Principle and Culture
Corporate Governance
Business Model
Origins of Our Corporate Name and Logo
Facilities
Access
Press Release
Research & Development
Collaboration
Partnering in Research
What are Research Tools?
Research Tool Licensing
Product Information
Anidulafungin
Ziprasidone
Dalbavancin
EP4 Antagonist
Cyclooxygenase-2 (COX-2) Inhibitor
Ghrelin Receptor Agonist
5-HT4 Partial Agonist
Acid Pump Antagonist
5-HT2B Antagonist
CB2 Agonist
Motilin Receptor Agonist
Licensing
Shareholder and Investor Information
To our Shareholders and Investors
Vision, Management Principle and Culture
Corporate Governance
Stock Quotes
Outline of Securities Matters
IR Library
IR Calendar
Disclaimer
IR Related News
Understanding RaQualia Pharma! RaQualia FAQ
RaQualia's History
What does RaQualia Pharma do?
How Does RaQualia Earn Revenues?
What About Dividends?
What are RaQualia's strengths?
What Does the Future Hold for RaQualia Pharma?
Corporate Introduction Video
Contributions to Society
Corporate Contributions
Contributions to the Community
Press Release
Topics